Shockwave Therapy for ED (2026): Does GAINSWave Work?

Shockwave therapy for ED is low-intensity extracorporeal shock wave therapy (Li-ESWT): a handheld probe sends low-energy acoustic pulses into the penis over a series of short sessions. The idea is that the pulses cause mild tissue stress that may prompt new blood vessel growth and better blood flow. It is not the high-energy shockwave used to break kidney stones.

Clinics market it as drug-free and non-invasive, and many pair it with other cash-pay services. It is aimed mainly at vascular ED, the kind caused by reduced blood flow. It is not designed to fix ED from nerve damage, low testosterone, medication side effects or anxiety.

The evidence is not settled. The AUA guideline says low-intensity shockwave therapy should be considered investigational for men with ED. It explains that findings from randomized sham-controlled trials do not clearly indicate that the benefits reliably outweigh the risks and burdens. That is a conditional recommendation based on Grade C evidence.

In plain terms: some trials report modest improvements, especially in milder vascular ED, but results vary across studies, devices and treatment protocols, and long-term durability is not established. There is also no agreed standard for how many sessions, at what energy, over what period. That variability is a large part of why the AUA does not treat it as standard care.

GAINSWave is a branded shockwave therapy protocol offered through affiliated clinics, not a separate kind of treatment. Its website describes it as a non-invasive protocol that uses shockwave devices and low-intensity sound waves. It says most people need six to twelve sessions, adjusted by the provider based on progress.

When we checked gainswave.com on October 30, 2026, the site did not publish a price, did not say whether insurance covers it, and did not make an FDA statement about the protocol. GAINSWave is a provider network, so the clinician, device and price can differ by location. The AUA guideline's investigational status applies to low-intensity shockwave therapy for ED in general, whatever the brand name.

We cannot give you a reliable price, because neither GAINSWave nor the AUA publishes one, and clinics set their own. What we can say is how the cost works:

• It is usually cash-pay. Because the AUA calls it investigational, do not assume your insurance will cover it. Ask your insurer directly.
• You pay per course. At six to twelve sessions per GAINSWave's own site, the total depends heavily on how many sessions a clinic recommends.
• Maintenance sessions add up. Ask whether the clinic expects follow-up sessions, and how much those cost.
• Get it in writing. Ask for the full course price, the refund policy, and what happens if you see no change.

For contrast, FDA-approved generic sildenafil and tadalafil are among the cheapest prescriptions in men's health. Our partners publish prices such as generic tablets from about $20 at HealthyMale, and see generic Viagra cost for more.

Low-intensity shockwave is non-invasive, but the AUA says trials do not clearly show its benefits reliably outweigh its risks and burdens, which is why it is called investigational. Ask the clinic about bruising, pain afterward and any reason you should not be treated, such as blood thinners, bleeding disorders or Peyronie's disease.

The larger safety issue is a missed diagnosis. ED can be an early warning sign of heart disease or diabetes. A clinic that sells shockwave without checking blood pressure, blood sugar, cholesterol and your medications is skipping the step that matters most. See ED causes and treatments.

The AUA guideline rates both as unproven: stem cell injections for ED should be considered investigational, and platelet-rich plasma (PRP, often sold as the "P-Shot") should be considered experimental. The guideline says PRP should not be offered unless it is given within an institutional review board approved research protocol. These are often bundled with shockwave packages, so read the treatment plan closely.

Shockwave is most often marketed to men with mild vascular ED who want to avoid daily or on-demand medication. If that is you, the safest path is to get a full evaluation first, try or at least discuss first-line treatment, and look for a clinical trial at a university urology department, where the therapy is studied with controls and follow-up.

Men with severe ED, ED after prostate surgery, or nerve-related ED have proven options that are more likely to work, including pills, vacuum erection devices and penile injections. If diabetes is part of your picture, see ED treatment for diabetes.

FDA-approved oral PDE5 inhibitors are the standard first-line drug treatment for ED. Sildenafil (generic Viagra) and tadalafil (generic Cialis) work for most men, are inexpensive as generics and are available through licensed telehealth after a consultation. They must never be combined with nitrates. We compare them in sildenafil vs. tadalafil.

Other established options include vacuum erection devices, urethral or injected alprostadil, and penile implants for men who do not respond to anything else. Lifestyle changes, like exercise, weight loss, quitting smoking and managing blood pressure and blood sugar, support every one of them.

• What is my diagnosis, and did you check my heart health, blood sugar and medications?
• Which device do you use, at what energy, and how many sessions do you recommend?
• What is the total price, including any maintenance sessions, and what is the refund policy?
• What results do you track, and how will we measure whether it worked?
• Why shockwave instead of first-line medication for me?
• Is this part of a clinical trial?

A clinic that cannot answer these clearly, or pushes a package on the first visit, is a reason to walk away.

• AUA guideline statements 23 to 25 (shockwave and stem cells investigational, PRP experimental): Erectile Dysfunction: AUA Guideline (2018), Burnett AL et al, J Urol 2018;200:633
• GAINSWave protocol and session count: gainswave.com (checked 2026-10-30; no price, insurance or FDA statement published)
• Sildenafil: MedlinePlus, Sildenafil; tadalafil: MedlinePlus, Tadalafil

This article is for adults 18 and older and is educational, not medical advice. Low-intensity shockwave therapy for ED is considered investigational by the AUA. Prescription ED medications require a consultation with a licensed clinician. GAINSWave is named for editorial reference only; ED Samples has no relationship with it and does not sell or provide any treatment.